The Neurorestorative Benefit of GW3965 Treatment of Stroke in Mice
- 1 January 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (1) , 153-161
Abstract
Background and Purpose—: GW3965, a synthetic liver X receptor agonist, elevates high-density lipoprotein cholesterol and has antiatherosclerosis and anti-inflammation properties. We tested the hypothesis that GW3965 treatment of stroke increases vascular remodeling, promotes synaptic protein expression and axonal growth in the ischemic brain, and improves functional outcome in mice. Methods—: Mice were subjected to transient middle cerebral artery occlusion and treated without or with different doses of GW3965 (5, 10, or 20 mg/kg) starting 24 hours after middle cerebral artery occlusion daily for 14 days. Neurological functional tests, blood high-density lipoprotein cholesterol measurement, and immunostaining were performed. Mouse brain endothelial cells, primary cultured artery explants, and primary cortical neurons cultures were also used in vitro. Results—: GW3965 treatment of stroke significantly increased blood high-density lipoprotein cholesterol level, synaptic protein expression, axonal density, angiogenesis and arteriogenesis, and Angiopoietin1, Tie2, and occludin expression in the ischemic brain and improved functional outcome compared with middle cerebral artery occlusion control animals (n=10; P P <0.05). Conclusions—: These data indicate, for the first time, that GW3965 promotes synaptic protein expression and axonal growth and increases vascular remodeling, which may contribute to improvement of functional outcome after stroke. Increasing Angiopoietin-1/Tie2 signaling activity may play an important role in GW3965-induced brain plasticity and neurological recovery from stroke.Keywords
This publication has 32 references indexed in Scilit:
- Niacin Treatment of Stroke Increases Synaptic Plasticity and Axon Growth in RatsStroke, 2010
- Predictors and assessment of cognitive dysfunction resulting from ischaemic strokeThe Lancet Neurology, 2010
- Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-κBNeuroscience, 2010
- Treatment of Stroke with a Synthetic Liver X Receptor Agonist, TO901317, Promotes Synaptic Plasticity and Axonal Regeneration in MiceJournal of Cerebral Blood Flow & Metabolism, 2009
- Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, β1-integrin-dependent mannerNeuroscience Research, 2009
- eNOS Mediates TO90317 Treatment-Induced Angiogenesis and Functional Outcome After Stroke in MiceStroke, 2009
- Expression of liver X receptor β is essential for formation of superficial cortical layers and migration of later-born neuronsProceedings of the National Academy of Sciences, 2008
- Adipocyte‐derived angiopoietin‐1 supports neurite outgrowth and synaptogenesis of sensory neuronsJournal of Neuroscience Research, 2006
- Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cellsThe International Journal of Biochemistry & Cell Biology, 2006
- Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for Tie-2 receptorCell and tissue research, 2005